selected publications
-
academic article
- A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 32:1834-1846. 2019
- Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties.. Neuron. 102:786-800.e5. 2019
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. 2017
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. 53:800-811. 2016
- Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.. International journal of epidemiology. 45:1619-1630. 2016
- Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.. Human genetics. 135:741-756. 2016
- A targeted genetic association study of epithelial ovarian cancer susceptibility.. Oncotarget. 7:7381-7389. 2016
- Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.. Genetic epidemiology. :-. 2015
- Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. :-. 2015
- Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.. Human molecular genetics. :-. 2015
- Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.. Gynecologic oncology. 136:542-548. 2015
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
- Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.. Nature communications. 6:-. 2015
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.. Gynecologic oncology. -. 2015